SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Leo Francis who wrote (2216)11/7/1997 4:39:00 PM
From: James Baker  Read Replies (1) | Respond to of 23519
 
leo:
<<<If VVUS's does not come out with a much stronger response, meaning
directly from one of the officers, versus an IR person, the stock could
dive deeper, as the print media picks up the story.

Something to think about, among all the other "Viagrables".>>>

Leo, I have to side with those who say this unfortunate death is likely to have MORE impact on viagra which afterall is not even FDA approved yet than it will MUSE. An orally taken, systemic drug just has to have more variety and more serious side effect potential.



To: Leo Francis who wrote (2216)11/7/1997 4:48:00 PM
From: Don Dunlap  Read Replies (1) | Respond to of 23519
 
Leo, Congrats on the profits. I let my greed get the best of me and have watched my profits almost disappear for the 2nd time. Two quarters ago I sold half my shares the day before earnings. Last quarter, I decided to hold on to my regret. Monday monring QB. In December, we will see if we get our typical run up the month before earnings.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News